News about Global Pharma

Zydus and Dr. Reddy to Co-Market Pertuzumab Biosimilar in India

Zydus Lifesciences and Dr. Reddy’s Laboratories Ltd. have announced the execution of a licensing agreement to co-market Pertuzumab biosimilar in India.

Global Pharma | 05/07/2024 | By Aishwarya |  2127

EMA Approves Marketing Authorization Application of Nidlegy

Philogen and Sun Pharmaceutical Industries Ltd. have announced that the European Medicines Agency (EMA) validated the submission of the Marketing Authorization Application (MAA) for Nidlegy.

Global Pharma | 05/07/2024 | By Aishwarya |  536

Quest Diagnostics Plans to Acquire LifeLabs from OMERS

Quest Diagnostics has signed a definitive agreement with OMERS to acquire LifeLabs, a trusted provider of community laboratory tests for millions of Canadians, for a value of approximately CAD 1.35 billion (approximately USD 985 million), including net debt.

Global Pharma | 04/07/2024 | By Aishwarya |  791

EMA Approves Dupixent as First-Ever Targeted Therapy for Patients with COPD

The European Medicines Agency (EMA) has recently announced their approval for Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD) characterized by raised blood eosinophils.

Global Pharma | 04/07/2024 | By Aishwarya |  636

Heron Therapeutics Announces Acceptance of the PAS Application for ZYNRELEF

Heron Therapeutics, Inc. has announced that the FDA acknowledged the receipt of the company's Prior Approval Supplement (PAS) application for ZYNRELEF (bupivacaine and meloxicam) extended-release solution VAN.

Global Pharma | 04/07/2024 | By Aishwarya |  656

Tobin Scientific Announces Acquisition of BioRepository Resources

Tobin Scientific has acquired BioRepository Resources LLC (BRR), a leader in biological sample storage and management solutions, located in New Providence, New Jersey.

Global Pharma | 03/07/2024 | By Aishwarya |  1057

Techinvention Lifecare Joins BVI as Consultant for Veterinary Vaccine Manufacturing Facility

Techinvention Lifecare Pvt. Ltd. has announced its appointment as a consultant by Botswana Vaccine Institute (BVI) to monitor the setting up of the new state-of-the-art and cGMP-compliant, vaccine manufacturing unit in its existing facility at Gaborone, Botswana.

Global Pharma | 03/07/2024 | By Aishwarya |  490

Genezen to Acquire uniQure Commercial Gene Therapy Manufacturing Operations in Lexington

Genezen has inked an agreement to acquire uniQure's commercial gene therapy operations in Lexington, MA, bringing a strategic manufacturing facility and a world-class team of employees to the company.

Global Pharma | 02/07/2024 | By Aishwarya |  867

Anbogen Therapeutics Secures Additional USD 7.3 Million in A+ Round Financing

Anbogen Therapeutics, Inc. has received USD 7.3 million oversubscribed A+ round financing, which is a direct continuation of the USD 12.5 Million Series A on February 1, 2024, bringing the total raised to USD 19.8 million.

Global Pharma | 02/07/2024 | By Aishwarya |  1062

Avanos Medical Appoints Indrani Franchini to Board of Directors

Franchini served as Executive Vice President and Chief Legal Officer at Alnylam Pharmaceuticals. From June 2017 to July 2021, she served as Executive Vice President and Chief Compliance Officer at Alexion Pharmaceuticals, Inc., where she led a comprehensive transformation of the company's compliance program.

Global Pharma | 01/07/2024 | By Manvi |  213